Evidence map›Paper›PMID 35889344›Full record

ArticleMolecules (Basel, Switzerland)2022

Dimethyl Sulfoxide: A Bio-Friendly or Bio-Hazard Chemical? The Effect of DMSO in Human Fibroblast-like Synoviocytes.

Manuel Gallardo-Villagrán, Lucie Paulus, David Yannick Leger, Bruno Therrien, Bertrand Liagre

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cytological profiling of trypanocidal principles fromPhytomedicine plus : international journal of phytotherapy and phytopharmacology · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Manuel Gallardo-VillagránInstitut de Chimie, Université de Neuchâtel, Avenue de Bellevaux 51, CH-2000 Neuchâtel, Switzerland.ORCID 0000-0001-8500-6185
Lucie PaulusLaboratoire PEIRENE UR 22722, Faculté de Pharmacie, Université de Limoges, F-87025 Limoges, France.
David Yannick LegerLaboratoire PEIRENE UR 22722, Faculté de Pharmacie, Université de Limoges, F-87025 Limoges, France.
Bruno TherrienInstitut de Chimie, Université de Neuchâtel, Avenue de Bellevaux 51, CH-2000 Neuchâtel, Switzerland.ORCID 0000-0002-0388-2745
Bertrand LiagreLaboratoire PEIRENE UR 22722, Faculté de Pharmacie, Université de Limoges, F-87025 Limoges, France.ORCID 0000-0003-4148-2598
Université de Limoges · FRUniversity of Neuchâtel · CH

Funding

European Union's Horizon 2020 under the Marie Sklodoska-Curie no. 764837
6 · The paper itself

Abstract

The effect of dimethyl sulfoxide (DMSO) in rheumatoid arthritis (RA) human fibroblast-like synoviocytes (FLSs) has been studied on five different samples harvested from the joints (fingers, hands and pelvis) of five women with RA. At high concentrations (>5%), the presence of DMSO induces the cleavage of caspase-3 and PARP-1, two phenomena associated with the cell death mechanism. Even at a 0.5% concentration of DMSO, MTT assays show a strong toxicity after 24 h exposure (≈25% cell death). Therefore, to ensure a minimum impact of DMSO on RA FLSs, our study shows that the concentration of DMSO has to be below 0.05% to be considered safe.

Indexed as

Arthritis, RheumatoidSynoviocytesApoptosisCell ProliferationCells, CulturedDimethyl SulfoxideFemaleFibroblastsHumansDimethyl Sulfoxidedimethyl sulfoxidefibroblast-like synoviocytesrheumatoid arthritis

Identifiers

PMID35889344
PMCPMC9318029
OpenAlexW4285392907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.